Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
Will participate also in the following events:
- Sachs Conference – BioPharma Obesity Innovation Forum
- The BIO@JPM Week Conference
Biophytis announces its participation in the inaugural BioPharma Obesity Innovation Forum (#Sachs_BOIF) on January 11, 2025, in San Francisco, as well as in the BIO@JPM Week conference during the 43rd annual JP Morgan Healthcare Conference, taking place from January 13 to 16, 2025, also in San Francisco.
The JP Morgan Healthcare Conference is the largest global healthcare event, bringing together industry leaders, innovative biotech companies, technology developers, and investors from the international financial community.
The BioPharma Obesity Innovation Forum, launching its first edition, will convene over 100 innovative companies, research organizations, and investors to address the challenges and advancements in obesity
treatments. Biophytis will present on January 11 at 1:50 PM to highlight its strategic positioning in the obesity domain, provide an update on its development program and outline its key milestones for 2025.
Additionally, Biophytis will participate in the BIO@JPM Week conference to enhance interactions with pharmaceutical partners and investors.